| Transferrin and the transferrin receptor: of magic bullets and other concerns MF Macedo, M Sousa Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets …, 2008 | 155 | 2008 |
| Transferrin is required for early T‐cell differentiation MF Macedo, M De Sousa, RM Ned, C Mascarenhas, NC Andrews, ... Immunology 112 (4), 543-549, 2004 | 70 | 2004 |
| Invariant natural killer T cells are phenotypically and functionally altered in Fabry disease CS Pereira, O Azevedo, ML Maia, AF Dias, C Sa-Miranda, MF Macedo Molecular genetics and metabolism 108 (4), 241-248, 2013 | 45 | 2013 |
| Control of CD1d-restricted antigen presentation and inflammation by sphingomyelin E Melum, X Jiang, KD Baker, MF Macedo, J Fritsch, CM Dowds, J Wang, ... Nature immunology 20 (12), 1644-1655, 2019 | 41 | 2019 |
| Low numbers of CD8+ T lymphocytes in hereditary haemochromatosis are explained by a decrease of the most mature CD8+ effector memory T cells MF Macedo, G Porto, M Costa, CP Vieira, B Rocha, E Cruz Clinical & Experimental Immunology 159 (3), 363-371, 2010 | 37 | 2010 |
| Identification of peptides for immunotherapy of cancer. It is still worth the effort MP Velders, JD Nieland, MP Rudolf, K Loviscek, S Weijzen, EE de Visser, ... Critical Reviews™ in Immunology 18 (1-2), 1998 | 33 | 1998 |
| Acid sphingomyelinase deficiency: a clinical and immunological perspective C Pinto, D Sousa, V Ghilas, A Dardis, M Scarpa, MF Macedo International journal of molecular sciences 22 (23), 12870, 2021 | 31 | 2021 |
| CD1‐Restricted T Cells at the Crossroad of Innate and Adaptive Immunity CS Pereira, MF Macedo Journal of immunology research 2016 (1), 2876275, 2016 | 30 | 2016 |
| Enzyme replacement therapy partially prevents invariant Natural Killer T cell deficiency in the Fabry disease mouse model MF Macedo, R Quinta, CS Pereira, MCS Miranda Molecular Genetics and Metabolism 106 (1), 83-91, 2012 | 26 | 2012 |
| From lysosomal storage diseases to NKT cell activation and back CS Pereira, H Ribeiro, MF Macedo International Journal of Molecular Sciences 18 (3), 502, 2017 | 23 | 2017 |
| Anomalies in conventional T and invariant natural killer T‐cell populations in Fabry mice but not in Fabry patients A Balreira, MF Macedo, C Girão, LG Rodrigues, JP Oliveira, ... British journal of haematology 143 (4), 601-604, 2008 | 23 | 2008 |
| Globotriaosylceramide inhibits iNKT‐cell activation in a CD1d‐dependent manner CS Pereira, C Sa‐Miranda, G De Libero, L Mori, MF Macedo European Journal of Immunology 46 (1), 147-153, 2016 | 21 | 2016 |
| Low serum transferrin levels in HFE C282Y homozygous subjects are associated with low CD8+ T lymphocyte numbers MF Macedo, E Cruz, R Lacerda, G Porto, M de Sousa Blood Cells, Molecules, and Diseases 35 (3), 319-325, 2005 | 18 | 2005 |
| Reduced glucosylceramide in the mouse model of Fabry disease: correction by successful enzyme replacement therapy R Quinta, D Rodrigues, M Assunção, MF Macedo, O Azevedo, D Cunha, ... Gene 536 (1), 97-104, 2014 | 17 | 2014 |
| Human T cell responses to endogenously presented HLA‐A* 0201 restricted peptides of Simian virus 40 large T antigen MP Velders, MF Macedo, M Provenzano, AG Elmishad, HG Holzhütter, ... Journal of Cellular Biochemistry 82 (1), 155-162, 2001 | 17 | 2001 |
| The iNKT Cell–Macrophage Axis in Homeostasis and Disease MS Cruz, JP Loureiro, MJ Oliveira, MF Macedo International Journal of Molecular Sciences 23 (3), 1640, 2022 | 13 | 2022 |
| Lipid antigen presentation by CD1b and CD1d in lysosomal storage disease patients CS Pereira, B Pérez-Cabezas, H Ribeiro, ML Maia, MT Cardoso, AF Dias, ... Frontiers in immunology 10, 1264, 2019 | 12 | 2019 |
| Invariant natural killer T cells are reduced in hereditary hemochromatosis patients ML Maia, CS Pereira, G Melo, I Pinheiro, MA Exley, G Porto, MF Macedo Journal of clinical immunology 35, 68-74, 2015 | 10 | 2015 |
| The biology of lysosomes: from order to disorder O Amaral, M Martins, AR Oliveira, AJ Duarte, I Mondragão-Rodrigues, ... Biomedicines 11 (1), 213, 2023 | 9 | 2023 |
| Psychosine variants as antigens for natural killer T cells S Deng, L Kain, CS Pereira, S Mata, MF Macedo, A Bendelac, L Teyton, ... Chemical Science 8 (3), 2204-2208, 2017 | 6 | 2017 |
de Visser Karin. EProfessor at the LUMC, group leader at the Netherlands Cancer Institute and Oncode Institute在 nki.nl 的电子邮件经过验证
de Visser Karin. EProfessor at the LUMC, group leader at the Netherlands Cancer Institute and Oncode Institute在 nki.nl 的电子邮件经过验证